¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѺÎÀÎÁ¾¾çÇÐȸ ÇÏ°èÇмú´ëȸ(Á¦16Â÷ ÀþÀºÀÇ»ç¿öÅ©¼¥ & Á¦5Â÷ ºÐ°úÀü¹®ÀÇ¿¬¼ö°­ÁÂ) : 2022-08-21

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѺÎÀÎÁ¾¾çÇÐȸ ÇÏ°èÇмú´ëȸ(Á¦16Â÷ ÀþÀºÀÇ»ç¿öÅ©¼¥ & Á¦5Â÷ ºÐ°úÀü¹®ÀÇ¿¬¼ö°­ÁÂ) : 2022-08-21
±³À°ÀÏÀÚ : 2022-08-21
±³À°Àå¼Ò : ¿ë»ê ¹é¹ü±è±¸±â³ä°ü  
±³À°ÁÖÁ¦ : ´ëÇѺÎÀÎÁ¾¾çÇÐȸ ÇÏ°èÇмú´ëȸ(Á¦16Â÷ ÀþÀºÀÇ»ç¿öÅ©¼¥ & Á¦5Â÷ ºÐ°úÀü¹®ÀÇ¿¬¼ö°­ÁÂ)
ÁÖÃÖ±â°ü : ´ëÇѺÎÀÎÁ¾¾çÇÐȸ
´ã´çÀÚ : ÁöÀºÁ¤
¿¬¶ôó : 02-512-5915  
À̸ÞÀÏ : gyncancer@gyncancer.or.kr      
±³À°Á¾·ù : »êºÎÀΰú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 10ºÐ  
¼¼ºÎ¼ö°­·á : 50,000¿ø      
ºñ°í Àü¹®ÀÇ 5¸¸¿ø, Àü°øÀÇ/°£È£»ç/¿¬±¸¿ø 3¸¸¿ø, ¿¬ÀÚ/ÁÂÀå/¸¸65¼¼ÀÌ»ó ¹«·á      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 09:40~09:55 Efficacy of single-dose HPV vaccination  ¿À¿µÅÃ(°­¿øÀÇ´ë) 
Åä·Ð 08-21 ÄÁº¥¼ÇȦ 09:55~10:00 Discussion  À̽ÅÈ­(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 10:00~10:15 Prognostic analysis of splenic parenchymal metastasis in advanced ovarian cancer: Does parenchymal metastasis matter?  ±èÁö¿¬(¾ÆÁÖÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 10:15~10:30 Clinical association of red blood cell distribution as prognostic marker in endometrial carcinoma  ÀÌÅ°æ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 10:30~10:45 Optimal cytoreduction and platinum-free interval affecting the duration of bevacizumab-based maintenance therapy and prognosis in the first platinum-sensitive recurrence of ovarian cancer  ¿À¼öÇö(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 10:45~11:00 Survival of incidentally found gynecologic cancer patients: multi-center retrospective study  À̼öÁ¤(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 11:00~11:15 Comparison of minimally invasive versus open surgery in treatment of endometrial cancer with high risk of recurrence  ÀåÁö¼±(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 11:15~11:30 Clinical implications of ovarian tumor size at diagnosis in patients with mucinous ovarian cancer  ÀÓÇöÁö(¼­¿ïÀÇ´ë) 
Åä·Ð 08-21 ÄÁº¥¼ÇȦ 11:30~11:40 Distillation  ÀÌ»êÈñ¹Ú¼ºÅÃ(¿¬¼¼¿øÁÖÀÇ´ëÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 11:40~12:00 Abdominal and pelvic anatomy for gynecologic oncology surgery  À±º¸¼º(Â÷ÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 12:00~12:20 Radiologic evaluation for resectability of gynecologic cancer: surgeon¡¯s perspective  À̼ºÁ¾(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 12:20~12:40 The role of lymphadenectomy in the management of gynecologic cancer  ½É½ÂÇõ(°Ç±¹ÀÇ´ë) 
Åä·Ð 08-21 ÄÁº¥¼ÇȦ 12:40~12:50 Discussion  ±èÁ¤½Ä(¼øõÇâÀÇ´ëÇѾçÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 12:50~13:10 My experience of dV cervical cancer  ÃÖöÈÆ(¼º±Õ°üÀÇ´ë) 
½Ä»ç 08-21 ÄÁº¥¼ÇȦ 13:10~14:00 Lunch  () 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 14:00~14:20 How to easily perform pelvic lymph node dissection: basic anatomy and spaces  ³²ÀºÁö(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 14:20~14:40 Type of radical hysterectomies: from piver-rutledge-smith to present day  ¹Î°æÁø(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 14:40~15:00 Principles and application of surgical staplers and vessel sealers  À̹æÇö(ÀÎÇÏÀÇ´ë) 
Åä·Ð 08-21 ÄÁº¥¼ÇȦ 15:00~15:10 Discussion  ÀÌö¹Î(Â÷ÀÇ´ë±¹¸³¾Ï¼¾ÅÍ) 
È޽Ġ08-21 ÄÁº¥¼ÇȦ 15:10~15:40 Coffee break  () 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 15:40~16:00 Liver mobilization for full evaluation and resection of diaphragm  ¼­µ¿ÈÆ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 16:00~16:20 Surgical approach for resection of pelvic sidewall tumors  ±èÈñ½Â(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 16:20~16:40 Splenectomy & distal pancreatectomy: surgical techique and postoperative care  ÀÓ°¡¿ø(µ¿±¹ÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 16:40~17:00 Shall we do our bowel surgery? (gynecologic oncologist perspective)  ÀÌÀ¯¿µ(¼º±Õ°üÀÇ´ë) 
Åä·Ð 08-21 ÄÁº¥¼ÇȦ 17:00~17:10 Discussion  ±èÀ±È¯ÃÖÇöÁø(ÀÌÈ­ÀÇ´ëÁß¾ÓÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѺÎÀÎÁ¾¾çÇÐȸ ÇÏ°èÇмú´ëȸ(Á¦16Â÷ ÀþÀºÀÇ»ç¿öÅ©¼¥ & Á¦5Â÷ ºÐ°úÀü¹®ÀÇ¿¬¼ö°­ÁÂ) : 2022-08-21""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦8ȸ ´ëÇѽŰæ¿Ü°ú º´¿øÇùÀÇȸ Çмú´ëȸ : 2022-08-21
´ÙÀ½±Û (¿Â¶óÀÎ) ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ 2022³âµµ ÀÓ»ó³úÆÄ ÇÏ°è ¿öÅ©¼ó : 2022-08-20
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20312 ¼­¿ï ¼¼°èÀ¯¹æ¾ÏÇмú´ëȸ 2024 ¹× Çѱ¹À¯¹æ¾ÏÇмú´ëȸ (GBCC 2024) (3ÀÏÂ÷) : 2024-04-27 0 106 2024-04-03
20311 ºÎ»ê ÇØ¿î´ë¹éº´¿ø ½Å°æ°ú ½ÉÆ÷Áö¿ò : 2024-04-27 0 143 2024-04-03
20310 ¼­¿ï Á¦29Â÷ ´ëÇÑÁÖ»êÀÇÇÐȸ Ãá°è¿¬¼ö°­Á : 2024-04-27 0 138 2024-04-03
20309 ¼­¿ï 2024³â ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ Á¦22Â÷ Á¤±âÇмú´ëȸ : 2024-04-27 0 88 2024-04-03
20308 ¼­¿ï 2024 ´ëÇÑÇ÷¾×ÇÐȸ Ç÷ÀüÁöÇ÷¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-04-27 0 126 2024-04-03
20307 °æ±â (¿Â¶óÀÎ) 2024³â Á¦1Â÷ °í·Á´ëÇб³ ¾È»êº´¿ø Á¤Çü¿Ü°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-04-27 0 131 2024-04-03
20306 ¼­¿ï 2024³â Çѱ¹½Å°æ¾È°úÇÐȸ Workshop : 2024-04-27 0 138 2024-04-03
20305 ¼­¿ï ¼¼°èÀ¯¹æ¾ÏÇмú´ëȸ 2024 ¹× Çѱ¹À¯¹æ¾ÏÇмú´ëȸ (GBCC 2024) (2ÀÏÂ÷) : 2024-04-26 0 74 2024-04-03
20304 Á¦ÁÖ 2024 ´ëÇÑÀÓ»ó¾à¸®ÇÐȸ Ãá°èÇмú´ëȸ : 2024-04-26 0 78 2024-04-03
20303 ÀüºÏ ´ëÇÑ°£ÇÐȸ ÀüºÏÁöȸ Á¦28Â÷ ¿¬¼ö±³À° : 2024-04-26 0 56 2024-04-03
20302 ¼­¿ï Á¦7ȸ º¸°ÇÀÇ·á BIG DATA ¿¬±¸ Çмú´ëȸ : 2024-04-26 0 107 2024-04-03
20301 ¼­¿ï ´ëÇÑÀÇÇÐÀ¯ÀüÇÐȸ Á¦39Â÷ Ãá°è¿¬¼ö°­Á : 2024-04-25 0 89 2024-04-03
20300 ¼­¿ï ´ëÇÑÀÇÇÐÀ¯ÀüÇÐȸ Á¦67Â÷ Ãá°èÇмú´ëȸ : 2024-04-25 0 147 2024-04-03
20299 ¼­¿ï ¼¼°èÀ¯¹æ¾ÏÇмú´ëȸ 2024 ¹× Çѱ¹À¯¹æ¾ÏÇмú´ëȸ (GBCC 2024) (1ÀÏÂ÷) : 2024-04-25 0 82 2024-04-03
20298 ¼­¿ï (¿Â¶óÀÎ) 2024³â Á¦2Â÷ û¼Ò³âÀÇÇÐ Áý´ãȸ(Áö¹æ°£Áúȯ, Çлý°Ç°­°ü¸®) : 2024-04-25 0 99 2024-04-03
61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷